This is my archive
PLUS: Promoting Lung Cancer Screening Among Screening-Eligible Individuals in Environmentally Burdened Communities Through Enhanced Risk Communication
Project Description In the city of Philadelphia, lung cancer incidence and mortality rates exceed state and national rates. Both smoking and air pollutants are known risk factors for lung…
Optimizing Biomarker Detection and Extending Life for Patients with Non-Small Cell Lung Cancer
Project Description When patients are diagnosed with metastatic, non-squamous non-small cell lung cancer (NSCLC), biomarker testing is crucial to determine the optimal treatment. For example, for the 30% of…
Increasing Lung Cancer Screening Through Connected Health
Project Description Implementation of annual lung cancer screenings (LCS) across the United States remains low (estimated 5% screening-eligible population screened). There are several challenges contributing to low implementation rates,…
Text Messaging and Take-At-Home Tests Boost Colorectal Cancer Screening
Project Description By providing the opportunity for early discovery and curative treatment, regular screenings have been shown to reduce mortality rates for colorectal cancer (CRC). Unfortunately, regular screening rates…
Increasing Rates of Serious Illness Conversations through Patient and Clinician Nudges
Project Description A national guideline-endorsed practice, serious illness conversations (SICs) are an opportunity for patients to share their wishes, care preferences, values, and goals as their disease progresses. They…
Connected Health Approaches to Improve Serious Illness Communication Among Patients with Incurable Cancer
Project Description Many patients with incurable cancer undergo treatment and acute care utilization that is discordant with their preferences, particularly near the end of life. Early conversations about prognosis…
Nudges Informed by Behavioral Economics to Increase Utilization of Higher-Value Cancer Drugs
Project Description Identifying effective ways to promote high-value, evidence-based prescribing is particularly important in cancer care, where spending is estimated to surpass $170 billion by 2020, driven in large…
iSMART: Implementation Strategies for Monitoring Adherence in Real Time for Oral Anticancer Therapies
Project Description Oral therapies in the treatment of lung cancer have unique side effect profiles that can lead to suboptimal adherence if not adequately managed, contributing ultimately to decreased…
Use of Social Incentives to Change Behaviors, Improve Ambulation and Health Outcomes After Major Abdominal Surgeries for Cancer
Project Description Major surgeries for cancer bear significant risks, especially for an at-risk elderly population. For cystectomies (removal of the bladder for bladder cancer), 67% of patients will have…
Justin Bekelman
Marietta and Howard Stoeckel Professor, Perelman School of Medicine Justin E. Bekelman, M.D. is the founding Director of the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer…